VINCRISTINE TEVA
1MG/ML INJ SOL 1X2ML
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Resumption of marketing | 20.05.2022 | Neplatné hlášení | ||
| Interruption of marketing | 31.10.2022 | Lék není nahraditelný | Commercial/marketing reasons | 30.11.2022 |
| Resumption of marketing | 07.01.2022 | |||
| Interruption of marketing | 31.01.2022 |
0011420 |
Manufacturing reasons | únor 2022 |
| Resumption of marketing | 01.10.2019 | |||
| Interruption of marketing | 15.09.2019 |
0011420 |
Manufacturing reasons | 9-10/2019 |
| Resumption of marketing | 20.12.2016 | |||
| Interruption of marketing | 01.12.2016 |
0011420 |
||
| Resumption of marketing | 15.10.2013 | |||
| Interruption of marketing | 17.09.2013 |
0011420 |
||
| Resumption of marketing | 27.06.2011 | |||
| Interruption of marketing | 06.06.2011 |
0011420 |
All reports are available in the Overview.
cz